PL117466B1 - Process for preparing novel derivatives of phenylopiperazine - Google Patents

Process for preparing novel derivatives of phenylopiperazine Download PDF

Info

Publication number
PL117466B1
PL117466B1 PL1977197550A PL19755077A PL117466B1 PL 117466 B1 PL117466 B1 PL 117466B1 PL 1977197550 A PL1977197550 A PL 1977197550A PL 19755077 A PL19755077 A PL 19755077A PL 117466 B1 PL117466 B1 PL 117466B1
Authority
PL
Poland
Prior art keywords
piperazine
methyl
group
formula
carbon atoms
Prior art date
Application number
PL1977197550A
Other languages
English (en)
Polish (pl)
Other versions
PL197550A1 (pl
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of PL197550A1 publication Critical patent/PL197550A1/xx
Publication of PL117466B1 publication Critical patent/PL117466B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/42Singly bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PL1977197550A 1976-04-23 1977-04-22 Process for preparing novel derivatives of phenylopiperazine PL117466B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB16526/76A GB1575904A (en) 1976-04-23 1976-04-23 Phenyl piperazines

Publications (2)

Publication Number Publication Date
PL197550A1 PL197550A1 (pl) 1979-05-21
PL117466B1 true PL117466B1 (en) 1981-08-31

Family

ID=10078930

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1977197550A PL117466B1 (en) 1976-04-23 1977-04-22 Process for preparing novel derivatives of phenylopiperazine

Country Status (34)

Country Link
JP (1) JPS52151183A (en:Method)
AR (2) AR222003A1 (en:Method)
AT (1) AT355579B (en:Method)
AU (1) AU514822B2 (en:Method)
BE (1) BE853899A (en:Method)
BG (2) BG27746A3 (en:Method)
CA (1) CA1087617A (en:Method)
CH (2) CH633009A5 (en:Method)
CS (1) CS196360B2 (en:Method)
DD (1) DD129790A5 (en:Method)
DE (1) DE2717415A1 (en:Method)
DK (1) DK176177A (en:Method)
ES (2) ES457988A1 (en:Method)
FI (1) FI63937C (en:Method)
FR (1) FR2348925A1 (en:Method)
GB (1) GB1575904A (en:Method)
GR (1) GR64084B (en:Method)
HU (1) HU176820B (en:Method)
IE (1) IE44730B1 (en:Method)
IL (1) IL51787A (en:Method)
LU (1) LU77170A1 (en:Method)
MX (1) MX4596E (en:Method)
NL (1) NL7704456A (en:Method)
NO (1) NO146710C (en:Method)
NZ (1) NZ183715A (en:Method)
OA (1) OA05643A (en:Method)
PH (1) PH14124A (en:Method)
PL (1) PL117466B1 (en:Method)
PT (1) PT66452B (en:Method)
RO (1) RO72831A (en:Method)
SE (1) SE7704536L (en:Method)
SU (2) SU664564A3 (en:Method)
YU (1) YU104477A (en:Method)
ZA (1) ZA771849B (en:Method)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1601310A (en) * 1978-05-23 1981-10-28 Lilly Industries Ltd Aryl hydantoins
DE3142608A1 (de) * 1981-10-28 1983-05-05 Basf Ag, 6700 Ludwigshafen Polyazofarbstoffe
JPH07157477A (ja) * 1993-12-02 1995-06-20 Asahi Kagaku Kogyo Kk チアゾール誘導体の製造方法
KR970701705A (ko) * 1994-03-11 1997-04-12 오노다 마사요시 5-HT₃ 수용체 효능제, 신규한 티아졸 유도체 및 이의 중간체(5-HT₃receptor agonist, novel thiazole derivative, and intermediate therefor)
CA2144669A1 (en) * 1994-03-29 1995-09-30 Kozo Akasaka Biphenyl derivatives
GB9517381D0 (en) * 1995-08-24 1995-10-25 Pharmacia Spa Aryl and heteroaryl piperazine derivatives
DZ3292A1 (fr) * 2001-09-13 2005-05-14 Solvay Pharm Gmbh Nouveaux composes de type 1-[1-(hetero)aryl-1-perhydroxyalkylmethyl]piperazine, methodes pour les preparer et medicaments renfermant cescomposes
US8927546B2 (en) 2006-02-28 2015-01-06 Dart Neuroscience (Cayman) Ltd. Therapeutic piperazines
WO2007100852A1 (en) 2006-02-28 2007-09-07 Helicon Therapeutics, Inc. Therapeutic piperazines as pde4 inhibitors

Also Published As

Publication number Publication date
IL51787A0 (en) 1977-05-31
PT66452B (en) 1979-03-09
AR222635A1 (es) 1981-06-15
CA1087617A (en) 1980-10-14
SU664564A3 (ru) 1979-05-25
SE7704536L (sv) 1977-10-24
DK176177A (da) 1977-10-24
ZA771849B (en) 1978-11-29
BG27746A3 (bg) 1979-12-12
ATA285177A (de) 1979-08-15
GR64084B (en) 1980-01-21
DE2717415A1 (de) 1977-11-10
CH625802A5 (en) 1981-10-15
BE853899A (fr) 1977-10-24
PL197550A1 (pl) 1979-05-21
IE44730B1 (en) 1982-03-10
PH14124A (en) 1981-02-26
NL7704456A (nl) 1977-10-25
CH633009A5 (en) 1982-11-15
ES457988A1 (es) 1978-07-16
NO146710B (no) 1982-08-16
DD129790A5 (de) 1978-02-08
FI771287A7 (en:Method) 1977-10-24
IE44730L (en) 1977-10-23
CS196360B2 (en) 1980-03-31
RO72831B (ro) 1983-07-30
NO771398L (no) 1977-10-25
IL51787A (en) 1980-02-29
ES467948A1 (es) 1978-11-01
LU77170A1 (en:Method) 1979-01-18
SU727146A3 (ru) 1980-04-05
MX4596E (es) 1982-06-25
AU514822B2 (en) 1981-02-26
NO146710C (no) 1982-11-24
HU176820B (en) 1981-05-28
BG28055A3 (bg) 1980-02-25
AU2438677A (en) 1978-10-26
AT355579B (de) 1980-03-10
AR222003A1 (es) 1981-04-15
JPS52151183A (en) 1977-12-15
PT66452A (en) 1977-05-01
NZ183715A (en) 1980-04-28
OA05643A (fr) 1981-04-30
RO72831A (ro) 1983-08-03
FR2348925B1 (en:Method) 1980-04-11
YU104477A (en) 1983-01-21
FI63937C (fi) 1983-09-12
FI63937B (fi) 1983-05-31
FR2348925A1 (fr) 1977-11-18
GB1575904A (en) 1980-10-01

Similar Documents

Publication Publication Date Title
EP0183191B1 (en) Thienylthiazole compounds
US5786355A (en) 4,6-diarylpyrimidine derivatives and salts thereof
GB2210368A (en) 2-aryl substituted heterocyclic compounds as antiallergic and anti-inflammatory agents
CS399991A3 (en) Amide derivatives
CS227015B2 (en) Method of preparing 2,4-di-substituted thiazol derivatives
JP2005533858A (ja) 化合物
EP0190015B1 (en) Novel 4h-1-benzopyran-4-ones and their sulphur containing analogs
SK278810B6 (sk) Derivát 2-aminotiazolu alebo 2-aminooxazolu a 5-am
PL117466B1 (en) Process for preparing novel derivatives of phenylopiperazine
PL78370B1 (en:Method)
US4857644A (en) Aryl sulfonopiperazines as anti-inflammatory agents
US4123529A (en) Phenylpiperazine derivatives
US20090012134A1 (en) Arylsulfonyl Benzofused Heterocycles as 5-Ht2a Antagonists
EP1861079A1 (en) Arylsulfonyl benzyl ethers as 5-ht2a antagonists
US4156729A (en) 1,2-Benzisothiazolin-3-ones
RU2041871C1 (ru) Производные бутеновой или пропеновой кислоты
CA2114183A1 (en) Pyridinium derivatives
DK168010B1 (da) Tetrahydroisoquinolinforbindelser og farmaceutisk middel indeholdende en saadan forbindelse
AU2005276233B2 (en) Diarylsulfones as 5-HT2A antagonists
JPH06122675A (ja) サッカリン誘導体タンパク質分解酵素阻害剤
PT92633A (pt) Processo para a preparacao de derivados cetonicos do furano com accao anti-retroviral e de composicoes farmaceuticas que os contem
CS216525B2 (en) Method of making the phenylpiperazine derivatives
PL139497B1 (en) Process for preparing novel derivatives of 1-/2-hydroxyphenyl/-alkanals and alkanones
US4190663A (en) Anti-thrombotic 1,2-benzisothiazolin-3-ones
PL164152B1 (pl) Sposób wytwarzania nowych pochodnych 2-iminobenzotiazoliny PL